Andrew J. Cutler

CNS pipeline · person

Andrew J. Cutler, MD

Scientific Advisor on the Cybin/Helus Pharma Scientific Advisory Board. Board-certified psychiatrist who has served as principal investigator on more than 400 clinical trials, with a focus on Phase II-IV mood disorder research.

  • 2 companies

Courtesy Autobahn Therapeutics

Current roles

Appears with

People sharing a company with Andrew.

People and affiliation data assembled from public company disclosures, SEC filings, and conference materials — every record source-cited under psychiatrist-authored guardrails.